Search results for SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL - ICH GCP - Clinical Trials Registry

ICH GCP | Clinical Trials Registry

Clinical Trials



1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 6548 Last


#
NCTID/Status
Study
Last Changed
1
NCT04233983
Not yet recruiting
Surgery Before Embryo Transfer in ERROR (Endometrioma Related Reduction in Ovarian Reserve)
Conditions: Endometriosis Related Infertility
Intervention: Laparoscopic Endometriosis Surgery
January 16, 2020
2
NCT04233970
Not yet recruiting
Development and Evaluation of a Web-based Programme on Relapse Management for People With Multiple Sclerosis
Conditions: Multiple Sclerosis, Relapsing-Remitting
Intervention: Web-based Intervention Programme, Web-based Information Material Offered Via The Same Platform (broca®) In Addition To Usual Care
January 16, 2020
3
NCT04233957
Recruiting
Dietary Sodium, Oxidative Stress, and Pulsatile Hemodynamics
Conditions: Sodium Excess
Intervention: High Sodium, Placebo
January 16, 2020
4
NCT04233944
Terminated
Uganda Birth Cohort Study
Conditions: Birth Outcomes; Stunting; Wasting; Anemia
January 16, 2020
5
NCT04233931
Completed
Mhealth for Pre-exposure Prophylaxis Adherence by Young Adult MSM
Conditions: Hiv
Intervention: PrEP Medication Adherence Mobile App
January 16, 2020
6
NCT04233918
Not yet recruiting
Evaluate the Efficacy and Safety of Evinacumab in Pediatric Patients With Homozygous Familial Hypercholesterolemia
Conditions: Homozygous Familial Hypercholesterolemia
Intervention: Evinacumab
January 16, 2020
7
NCT04233905
Completed
Factors Influencing Selective Mutism
Conditions: Selective Mutism
Intervention: Psychometric Questionnaire Study
January 16, 2020
8
NCT04233892
Recruiting
Clinical Study of in Situ Regeneration of Endometrium
Conditions: Infertility, Female, of Uterine Origin; Endometrial Fibrosis
Intervention: CBD-bFGF, Collagen/BMMNCs, Estrogen
January 15, 2020
9
NCT04233879
Not yet recruiting
Randomized, Double-blind, Efficacy, and Safety Study of Doravirine/Islatravir (DOR/ISL) in Treatment-naïve Participants With Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-020)
Conditions: HIV-1 Infection
Intervention: DOR/ISL, BIC/FTC/TAF, Placebo To BIC/FTC/TAF, Placebo To DOR/ISL
January 15, 2020
10
NCT04233866
Not yet recruiting
Comparing Two Treatment Combinations, Gemcitabine and Nab-Paclitaxel With 5-Fluorouracil, Leucovorin, and Liposomal Irinotecan for Older Patients With Pancreatic Cancer That Has Spread
Conditions: Metastatic Pancreatic Adenocarcinoma; Stage IV Pancreatic Cancer AJCC v8
Intervention: Fluorouracil, Gemcitabine, Gemcitabine Hydrochloride, Leucovorin, Leucovorin Calcium, Liposomal Irinotecan, Nab-paclitaxel, Quality-of-Life Assessment, Questionnaire Administration
January 16, 2020
11
NCT04233853
Recruiting
Consultation-Liaison Intervention for Patients With Depression and Anxiety in Primary Care
Conditions: Depression; Anxiety
Intervention: CoLiPri Intervention, Usual Primary Care Enhanced
January 16, 2020
12
NCT04233840
Recruiting
P1101 and Anti-PD1 for After Curative Surgery of Hepatitis B-related Hepatocellular Carcinoma
Conditions: Hepatocellular Carcinoma
Intervention: P1101 (Ropeginterferon Alfa-2b), Nivolumab
January 15, 2020
13
NCT04233827
Active, not recruiting
Mobile Biosensor for Measuring Vital Signs in Healthcare and Home Settings
Conditions: Pulse Oximetry
January 15, 2020
14
NCT04233814
Not yet recruiting
Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects
Conditions: Idiopathic Pulmonary Fibrosis
Intervention: Caveolin-1-Scaffolding-Protein-Derived Peptide (LTI-03), Placebo
January 15, 2020
15
NCT04233801
Not yet recruiting
A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin.
Conditions: Type 2 Diabetes
Intervention: Empagliflozin, Placebo
January 16, 2020
16
NCT04233788
Not yet recruiting
Metabolic Characterization of Space Occupying Lesions of the Brain
Conditions: Brain Tumor; Glioma; IDH Mutation
Intervention: MR-scans Using A 3T Prisma And A 7T Terra Scanner (Siemens, Erlangen Germany)
January 15, 2020
17
NCT04233775
Recruiting
Altered Cerebral Growth and Development in Infants With Congenital Heart Disease
Conditions: Neurodevelopmental Disorders; Congenital Heart Disease; Brain Injuries; Fetal Growth Retardation
January 15, 2020
18
NCT04233762
Recruiting
Effect of Sex Hormone During the Menstrual Cycle on Capsaicin Evoked Cough Responses
Conditions: Asthma
January 16, 2020
19
NCT04233749
Not yet recruiting
The Efficacy of Tranexamic Acid in the Treatment of Lichen Planus Pigmentosus and Erythema Dyschromicum Perstans
Conditions: Lichen Planus Pigmentosus; Erythema Dyschromicum Perstans; Ashy Dermatosis of Ramirez
Intervention: Tranexamic Acid Tablets
January 16, 2020
20
NCT04233736
Not yet recruiting
Erector Spinae Plane Blocks (ESP) for Postoperative Pain in Lumbo-sacral Spine Surgery
Conditions: Erector Spinae Plane Block; Lumbar Spine Surgery
Intervention: Bilateral Lumbar Erector Spinae Plane Block
January 15, 2020
21
NCT04233723
Not yet recruiting
Effect of Severe Trauma on PD1 and Its Legend (PD1/L1) on T Lymphocytes and Correlation With Mortality
Conditions: Trauma Patients
Intervention: Peripheral Blood Samples
January 16, 2020
22
NCT04233710
Recruiting
Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy
Conditions: Hemiplegic Cerebral Palsy; Perinatal Stroke
Intervention: Robot Rehabilitation + TDCS, Robotic Rehabilitation + Sham TDCS
January 15, 2020
23
NCT04233697
Not yet recruiting
Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma
Conditions: T-Cell Lymphoma Relapsed & Refractory
Intervention: Copanlisib, Romidepsin
January 15, 2020
24
NCT04233684
Recruiting
Rapid Urease Test for Helicobacter Pylori in Population Who Stop Proton Pump Inhibitor Less Than 2 Weeks Compared With Histology
Conditions: Helicobacter Pylori Infection
Intervention: Rapid Urease Test
January 15, 2020
25
NCT04233671
Not yet recruiting
Minds and Mentors Program (MiMP)- R61
Conditions: Opioid-use Disorder; Medication Assisted Treatment; Substance Use Disorders
Intervention: Mindfulness Based Relapse Prevention And Peer Mentoring
January 15, 2020
26
NCT04233658
Not yet recruiting
Cynara Scolymus Extract for Treatment of Diabetes Mellitus Type 2
Conditions: Diabetes Mellitus, Type 2
Intervention: Cynara Scolymus
January 16, 2020
27
NCT04233645
Not yet recruiting
Voiding Diary Video
Conditions: Urinary Incontinence
Intervention: 5-minute Educational Video, Usual Care
January 16, 2020
28
NCT04233632
Recruiting
Randomized Comparative Study of the Contraceptive Efficacy of the Cupid, Cupid 2 and FC2 Female Condom
Conditions: Pregnancy Prevention
Intervention: FC2 Condom, Cupid Condom, Cupid 2 Condom
January 14, 2020
29
NCT04233619
Recruiting
Correlation of Microvascular Ophthalmic Disease With Macrovascular Coronary Artery Disease in Trinidad
Conditions: to Determine if Retinal Artery Calibre is a Direct Correlation to the Coronary Artery Disease
Intervention: Optical Coherence Tomography
January 14, 2020
30
NCT04233606
Not yet recruiting
Influence of Osmotic Stimulation of Vasopressin on Autonomic Function
Conditions: Water Stress; Body Water Dehydration
Intervention: Hypertonic Saline, Normal Saline
January 15, 2020
31
NCT04233593
Recruiting
Neuroimmune Response to Lipopolysaccharide
Conditions: Healthy
Intervention: Lipopolysaccharide
January 16, 2020
32
NCT04233580
Not yet recruiting
Characterization of AmnioExcel Plus in Two Treatment Paradigms
Conditions: Diabetic Foot Ulcer
Intervention: Amnio Excel + Weekly, Amnio Excel + Max Every 2 Weeks
January 16, 2020
33
NCT04233567
Not yet recruiting
Infigratinib for the Treatment of Advanced or Metastatic Solid Tumors in Patients With FGFR Gene Mutations
Conditions: Advanced Malignant Solid Neoplasm; Cholangiocarcinoma; Metastatic Malignant Solid Neoplasm; Refractory Malignant Solid Neoplasm
Intervention: Infigratinib
January 15, 2020
34
NCT04233554
Not yet recruiting
Patient Priorities Care-North Carolina
Conditions: Multiple Chronic Conditions
Intervention: Patient Priorities Care
January 15, 2020
35
NCT04233541
Recruiting
Frailty Status and Increased Risk for Falls
Conditions: Frailty; Fall; Anticholinergic Toxicity
Intervention: Fall Assessment
January 15, 2020
36
NCT04233528
Recruiting
Evaluation of Systemic Microvascular Endothelial Function in Metabolically Healthy Obesity
Conditions: Obesity; Dyslipidemias
Intervention: Evaluation Of Systemic Skin Microvascular Endothelial Function
January 15, 2020
37
NCT04233515
Recruiting
Use of Oral Anticoagulants and Symptoms in Patients With Atrial Fibrillation in Örebro County
Conditions: Atrial Fibrillation; Stroke, Ischemic
Intervention: Oral Anticoagulant
January 15, 2020
38
NCT04233502
Not yet recruiting
Efficacy and Safety of Slenyto for Insomnia in Children With ASD
Conditions: Autism Spectrum Disorder
Intervention: Melatonin, Placebo
January 15, 2020
39
NCT04233489
Not yet recruiting
Clinical Interventions to Mitigate Neurodevelopmental Risk
Conditions: Child Development; Mother-Infant Interaction; Diabetes Mellitus, Gestational
Intervention: Family Nurture Intervention (FNI)
January 15, 2020
40
NCT04233476
Recruiting
A Study of 99mTc-3PRGD2 Injection in Lung Cancer Patient
Conditions: Lung Cancer Metastatic
Intervention: 99mTc-3PRGD2
January 16, 2020
41
NCT04233463
Not yet recruiting
The Effect of Oral Polymeric Diet Enriched With TGF-beta 2 (Modulen) on Clinical Response and Mucosal Healing in Adult Patients With Newly Diagnosed Crohn's Disease
Conditions: Crohn Disease
Intervention: Modulen, Budesonide
January 15, 2020
42
NCT04233450
Not yet recruiting
Perceptions of Their Own Body and of the Body of Their Child Among Young Mothers With Anorexia Nervosa
Conditions: Anorexia Nervosa; Eating Disorders
Intervention: Bodybabe Questionnaire
January 15, 2020
43
NCT04233437
Not yet recruiting
Drug-Drug Interaction Study of MLC1501 Using Cocktail of Drugs Acting as Sensitive Clinical Probes/Substrates of Cytochrome P450 Isoenzymes and Transporters in Healthy Subjects
Conditions: Stroke
Intervention: MLC1501, CYP Cocktail, Transporter Cocktail
January 15, 2020
44
NCT04233424
Not yet recruiting
D-PLEX 311: Safety and Efficacy of D-PLEX in the Prevention of Post Abdominal Surgery Incisional Infection
Conditions: Surgical Site Infection; Colon Surgery; Abdominal Surgery; Post-Op Infection
Intervention: D-PLEX, Standard Of Care (SoC)
January 16, 2020
45
NCT04233411
Completed
The Bioavailability of Mycoprotein
Conditions: Availability of Mycoprotein
Intervention: Mycoprotein Ingestion
January 15, 2020
46
NCT04233398
Not yet recruiting
HIFU Treatment of Benign Thyroid Nodules
Conditions: Thyroid Nodule (Benign)
Intervention: Device: Echopulse (HIFU Ablation)
January 15, 2020
47
NCT04233385
Not yet recruiting
Myofascial Massage for Pain and Immobility Following Breast Cancer Surgery
Conditions: Breast Cancer; Mastectomy; Lymphedema; Pain, Shoulder; Mobility Limitation
Intervention: Myofascial Massage, Light Touch
January 16, 2020
48
NCT04233372
Not yet recruiting
Evaluation of (Doravirine / Lamivudine / Tenofovir Disoproxil Fumarate) (Delstrigo®) as a New Strategy for Non-occupational Post Exposure Prophylaxis, a Prospective Open Label Study
Conditions: Hiv
Intervention: Delstrigo
January 16, 2020
49
NCT04233359
Recruiting
A Randomised Study Evaluating Diagnostics of Pleural Effusion Among Patients Suspect of Cancer.
Conditions: Pleural Effusion, Malignant; Pleural Effusion; Pleura; Exudate
Intervention: Local Anesthetic Thoracoscopy, US-guided Pleural Biopsy
January 15, 2020
50
NCT04233346
Not yet recruiting
The Study for CML Who Failed Prior TKIs or With T315I Mutation or Ph+ ALL Who Failed Prior TKIs or With T315I Mutation
Conditions: Chronic Myeloid Leukemia; Acute Lymphoblastic Leukemia
Intervention: Ponatinib
January 15, 2020

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 … 6529 6530 6531 6532 6533 6534 6535 6536 6537 6538 6539 6540 6541 6542 6543 6544 6545 6546 6547 6548 Last


Last Updated

The last updated date is the most recent date when changes to a clinical trial were submitted to ClinicalTrials.gov. There is often a delay of a few days before the updated trial is available on the clinical trials website.

Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.

Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.

First Received

The first received date is the date when the clinical trial was first submitted to ClinicalTrials.gov. There is often a delay of a few days before the trial is available on the clinical trials website.

Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.

Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.

Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.

Safety Issue

If selected, restricts search results to those studies which have an outcome measure designated as a safety issue. Note that this is a poor estimate of the safety of a treatment or intervention, but it is all we have now.

Funded By

Studies are supported by one or more organizations called sponsors. Support includes contributions of facilities, expertise, and/or financial resources. All sponsors in the database have been assigned one of the following organization types:

National Institutes of Health (NIH)

Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.

Industry - the pharmaceutical companies

University/Organization - all others, including community-based organizations

Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.

Study Phase

Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions that study is seeking to answer:

In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.

In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.

In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.

In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.

These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.

Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.

Age Group

Studies may be designed for participants of particular ages:

Children (birth-17 yrs old)

Adults (18-65 yrs old)

Senior (66+ yrs old)

Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.

Gender

Searches can be restricted to studies which accept female or male participants.
Location Terms

If you are interested in a specific city (such as Los Angeles) or facility name (such as the Mayo Clinic), enter it as a location term. Not all studies include this level of detail, but if they do, this will find them.

Countries and States

Trials are often conducted at many locations around the world. Select up to three locations to find trials conducted in specific countries. Some countries (currently limited to the United States, Canada, and Australia), locations can be narrowed further by selecting a state.

Study IDs

Each trial is assigned one or more identification numbers by the institute, agency, or organization sponsoring the trial. In addition, clinical trials assigns a unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit. Use this box to search for a trial by NCT identifier or any other study identification numbers.

Examples:

NCT00001789
97-h-0197
ia0006
actg 076

Sponsor (Lead)

Use this box to specify the name of an institute, organization, or company that is conducting a trial.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.

A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.

When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Examples:

National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators

Use this box to specify institutes, organizations, or companies that are conducting or otherwise supporting a trial.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.

Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.

When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Examples:

National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb

Outcome Measures

Outcome measures are used to evaluate trial results. For example, an obesity treatment might be evaluated by a measure of weight loss after 6 months. Measures can also be used to quantify side effects, such as number of myocardial infarctions, number of patients with heart arrhythmia, number of suicides, etc.

Use this box to specify an outcome measure used to evaluate trial results.

Examples:

weight loss
heart failure
suicide

Interventions

Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied. Interventions can also include less intrusive possibilities such as surveys, education, and interviews.

Use this box to specify drugs, devices, procedures, or vaccines used in a trial.

Examples:

clofibrate
cyclosporine
vitamin e

Conditions

Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov, conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.

Use this box to specify the conditions being studied.

Examples:

lupus
heart attack
leukemia
risk factors for breast cancer

Study Type

There are three types of studies available in ClinicalTrials.gov:

Interventional:

Studies where individuals are assigned to receive specific interventions. Participants may receive diagnostic, therapeutic or other types of interventions. Assignment of the intervention may or may not be random. Individuals are tracked and biomedical and/or health outcomes are assessed.

Observational:

Studies without an intervention. Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals. Participants may receive diagnostic, therapeutic, or other interventions, but the investigator does not assign specific interventions to the participants of the study.

Expanded Access:

Records describing the procedure for obtaining an experimental drug or device for patients who are failing on currently available treatments for their condition and also are unable to participate in ongoing clinical trials. Expanded Access records are used to register all types of non-protocol access to experimental treatments, including protocol exception, single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.

Study Results

Searches can be restricted to studies with or without results.

The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.

Recruitment Status

Also known as Enrollment Status.

Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.

If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.

Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.

Full list of all possible recruitment status values:

Open recruitment status values:

Recruiting,
Not yet recruiting, or
Available for expanded access.

Closed recruitment status values:

Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.

Values are color coded (as shown) in the search results.

Search Terms

Use this box to specify general search terms found anywhere in the trial record.

Multiple terms can be separated by an AND (all uppercase).

Examples:

type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study


Help for Searching clinical trials

Help Topics:
Basic Search
Advanced Search
Refine Search
Search Expressions


Basic Search:

On the Basic Search page, enter a word or word(s) that you want to use to find studies. These may include diseases, interventions, and/or locations.

Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks

A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.


Advanced Search:

Many searches are a single term and can be performed with a few words in the search box. But, sometimes you need more control. Click on the Advanced Search tab (if starting a new search) or Refine Search tab (if modifying an existing search) to show additional search fields.

The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.

Search Terms:
Performs a general search in all sections of the study record, including title, description, conditions, interventions, locations, etc. Terms in this field are searched the same as Basic Search.

Recruitment:
Limits search results to studies that are open or closed. New volunteers may be able to participate in open studies, but not closed studies.

Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.

Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.

Values are color coded (as shown) in the search results.

Study Results:
Limits search results based on whether the study has results or not:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov. Only a few studies have results available.

Study Type:
Limits search results to any of the following study types:
Interventional,
Observational, or
Expanded Access

Conditions:
Performs a search on fields describing the diseases or conditions being studied.

Interventions:
Performs a search on fields listing the drugs or interventions being studied.

Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.

Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.

When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Sponsor (Lead):
Performs a search on the sponsor field of a study.

It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.

When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.

Study IDs:
Performs a search on fields listing ID numbers.

Country/State:
Trials are often conducted at many locations around the world. Select up to three locations to find trials conducted in specific countries. Some countries (currently limited to the United States, Canada, and Australia), locations can be narrowed further by selecting a state (e.g., United States, Alabama).

Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic). Not all studies include this level of detail, but if they do, this will find them.

Gender:
Limits search results to those studies that accept female or male participants.

Age Group:
Limits search results to those studies that include at least one of the specified age ranges. More than one age group can be selected.

Phase:
Limits search results to studies that are labeled with at least one of the specified phases. More than one Phase can be selected.

Funded By:
Limits search results to studies that have at least one sponsor of the specified types. More than one sponsor type can be selected.

Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.

First Received:
Limits search results to studies that were received by clinical trials within a specified date range. The "From" or "To" field can be left blank.

Last Updated:
Limits search results to studies that were modified within a specified date range. The "From" or "To" field can be left blank.


Refine Search:

Searches display a list of studies found (List Results tab). If you are not content with the search results, click on the Refine Search tab at the top of the list to modify your search.

Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.

For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California

When you are done making changes, click Search to display the new results.


Search Expressions:

Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California

Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack

Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS

Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )

Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.

To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.

Conditions

Alphabetic (A-Z)
By Category

Rare Diseases

Alphabetic (A-Z)

Drug
Interventions

Alphabetic (A-Z)
By Category

Dietary
Supplements

Alphabetic (A-Z)
By Category

Sponsor/
Collaborators

Alphabetic (A-Z)
By Category

Locations

Alphabetic (A-Z)
By Category